Ferinject 50mg/ml Solution for Injection contains ferric carboxymaltose, a stable complex of iron designed for intravenous administration to treat iron deficiency when oral iron preparations are ineffective or cannot be used. It is primarily indicated for the treatment of iron deficiency anemia in adult patients with chronic kidney disease, heart failure, or other conditions where rapid iron replenishment is necessary. Ferric carboxymaltose allows for the controlled release of iron, facilitating efficient uptake and utilization by the body while minimizing the risk of free iron toxicity. The solution is administered by slow intravenous injection or infusion, with dosage tailored to the patient’s iron deficit and clinical condition, ensuring effective restoration of iron stores and hemoglobin levels. Ferinject offers the advantage of delivering high doses of iron in a single session, reducing the need for multiple administrations and improving patient compliance. Common side effects may include transient nausea, headache, dizziness, or injection site reactions, though serious adverse events are rare when used as directed. As with all iron therapies, monitoring of iron parameters and hypersensitivity reactions is recommended. Ferinject should be used under medical supervision with appropriate precautions in patients with known hypersensitivity to ferric carboxymaltose or any excipients.